• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE® EXCLUDER® ILIAC BRANCH ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE® EXCLUDER® ILIAC BRANCH ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Catalog Number HGB161007A
Device Problems Bent (1059); Difficult or Delayed Positioning (1157); Occlusion Within Device (1423); Material Separation (1562); Physical Resistance (2578); Difficult to Advance (2920)
Patient Problems Intimal Dissection (1333); Thrombus (2101)
Event Date 01/17/2017
Event Type  Injury  
Manufacturer Narrative
Concomitant medical products: (b)(4)/15162279 and (b)(4)/15212632.Udi numbers for the lots are as follows: (b)(4).The review of the manufacturing paperwork verified that the lots met all pre-release specifications.
 
Event Description
On (b)(6) 2017, the patient underwent treatment of an abdominal aortic aneurysm and a right common iliac artery aneurysm with gore® excluder® aaa endoprostheses and iliac branch endoprostheses.Pre-implantation imaging had identified a nonviable left internal iliac artery, therefore the physician planned to save the right internal iliac artery during the implant procedure.During the procedure, an iliac branch component was reportedly positioned and deployed as planned without any reported issues.It was reported the patient had very complex anatomy, a small right internal iliac artery (measuring less than 6mm in diameter) with evidence of calcification at the ostium of the artery.Further, it was reported the entry angle into the ostium was a greater than 90 degree left turn into the artery resulting in difficulty gaining guidewire access.Reportedly, the physician made numerous attempts to gain guidewire access into the right internal iliac artery, however the guidewire continued to ¿pop¿ out of the artery.It was reported, an up-and-over throughwire was established and several non-gore access catheters (manufacturers unknown) were used in an attempt to position the internal iliac component within the right internal iliac artery for deployment.During advancement of the internal iliac component resistance was encountered, reportedly the up and over through wires had become wrapped around the delivery catheter.According to the report, the device was removed from the patient and an intra-operative angiogram was performed.Reportedly, the intra-operative imaging showed a dissection at the bifurcation of the right internal and common iliac arteries.This dissection was reported to have resulted in a ¿flap¿ covering the ostium of the internal artery.It was reported the dissection did not result in significant blood loss nor was a transfusion of blood products required.Additional attempts were made to advance the delivery catheter past the flap covering ostium, when this failed the physician elected to again withdraw the delivery catheter from the patient.A visual inspection was performed which indicated the device had been damaged.Reportedly, the tip of the device appeared bent with a gap between the tip of the delivery catheter and the constrained endoprosthesis.The physician was reported to have stated the integrity of the device may have been compromised, therefore the device was discarded by the facility.A gore® viabahn® (10x5) endoprosthesis was then advanced and implanted into the right internal iliac artery.Another internal iliac component was prepared and advanced through a gore® 12 fr dryseal flex introducer sheath into position and implanted as a bridge between the viabahn endoprosthesis and the iliac branch component.The procedure continued with the implantation the trunk-ipsilateral leg and contralateral leg components on the patient¿s left side, without any reported issues.Intra-operative imaging showed the right side (non-ipsilateral side) of the iliac branch component, the internal iliac component and the viabahn endoprosthesis appeared fully occluded with thrombus.Reportedly, the cause of the device occlusion is unknown, however the physician stated the dissection possibly caused the thrombotic event.A contralateral leg component was implanted, extending distally from the bifurcation of the internal iliac component into the external iliac artery resulting in the intentional coverage of the right internal iliac artery.It was reported, at the conclusion of the procedure, final angiography showed good perfusion bilaterally to the distal extremities.The patient tolerated the procedure.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® EXCLUDER® ILIAC BRANCH ENDOPROSTHESIS
Type of Device
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
Manufacturer (Section G)
MEDICAL SUNNYVALE B/P
1327 orleans drive
sunnyvale CA 94089
Manufacturer Contact
charlene cooper
1500 n. 4th street
flagstaff, AZ 
9285263030
MDR Report Key6267707
MDR Text Key65452839
Report Number2953161-2017-00017
Device Sequence Number1
Product Code MIH
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P020004
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Reporter Occupation Physician
Type of Report Initial
Report Date 01/17/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date04/13/2019
Device Catalogue NumberHGB161007A
Device Lot Number14970853
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received01/20/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured04/13/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age57 YR
-
-